Sutro Biopharma, Inc.


Sutro Biopharma, Inc. Website Screenshot

http://www.sutrobio.com

Sutro Biopharma, Inc. Company Intro

Sutro Biopharma, Inc. is a public biotechnology company headquartered in South San Francisco, California focused on clinical stage drug discovery, development and manufacturing company. Using its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics for cancer and autoimmune disorders. It focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidates include STRO-001 and STRO-002. STRO-001 is an ADC directed against the cancer target CD74, for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002 is an ADC directed against folate receptor-alpha (FolRa), for patients with ovarian and endometrial cancers. STRO-001 and STRO-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its XpressCF platform.

Industry

Healthcare

Sutro Biopharma, Inc. Headquaters

310 Utah Avenue
South San Francisco,94080
United States


Sutro Biopharma, Inc. Share price

17 May 2023 13:57 GMT

$5.71

-0.02 (-0.35 %)


Sutro Biopharma, Inc. Market cap

$341.355 M


WMC RANKING

2023

Sutro Biopharma, Inc. # 100

Biotechnology

Latest Sutro Biopharma, Inc. News

News 19 Sep 2023

Sutro Biopharma Inc. (STRO) names Hans-Peter Gerber as ...

Sutro Biopharma, Inc. (NASDAQ: STRO) announced the appointment of Hans-Peter Gerber, Ph.D., as Chief Scientific Officer, effective September 18, 2023.

News 19 Sep 2023

Sutro Biopharma, Inc. Appoints Hans Peter Gerber as Chief ...

Sutro Biopharma, Inc. is a clinical-stage oncology company. The Company is engaged in developing site-specific and novel-format antibody drug conjugates (ADCs)...

News 19 Sep 2023

Sutro Biopharma Inc. (STRO) names Hans-Peter Gerber as ...

Sutro Biopharma, Inc. (NASDAQ: STRO) announced the appointment of Hans-Peter Gerber, Ph.D., as Chief Scientific Officer, effective September 18, 2023.


WMC Market Score


WMC Market to Revenue Score


Sutro Biopharma, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Sutro Biopharma, Inc. USD $50,230 $121,116 $-42,892 $3,414M 100
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $804,390B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $878,880B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $144,340B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Sutro Biopharma, Inc. Social Followers vs Top 4 Industry Competitors



Sutro Biopharma, Inc. Post vs Top 4 Industry Competitors




Sutro Biopharma, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Sutro Biopharma, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Sutro Biopharma, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Sutro Biopharma, Inc. 0.55 0.47 0.03 0 0 0 0.22
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 28 0 0 29.94
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 40 0 0 36.32
Alexion Pharmaceuticals, Inc. 68.08 100 100 32 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 45.31

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries